Evidence map›Paper›PMID 38719596›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Subarachnoid Hemorrhaging with Multiple Cerebral Artery Stenoses after Initiating Remission Induction Therapy for Eosinophilic Granulomatosis with Polyangiitis.

Haruka Yasuba, Hirotaka Yamada, Masaya Togo, Kento Matoba, Eriko Yamamoto Kashihara, Keisuke Nishimura, Sho Sendo, Yo Ueda, Jun Saegusa

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haruka YasubaDepartment of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Japan.
Hirotaka YamadaDepartment of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Japan.
Masaya TogoDivision of Neurology, Kobe University Graduate School of Medicine, Japan.
Kento MatobaDivision of Neurology, Kobe University Graduate School of Medicine, Japan.
Eriko Yamamoto KashiharaDepartment of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Japan.
Keisuke NishimuraDepartment of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Japan.
Sho SendoDepartment of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Japan.
Yo UedaDepartment of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Japan.
Jun SaegusaDepartment of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We encountered a 64-year-old Japanese woman who developed subarachnoid hemorrhaging (SAH) with multiple cerebral artery stenoses during remission induction therapy for eosinophilic granulomatosis and polyangiitis (EGPA). The treatment involved intensified steroid pulse therapy and continued intravenous cyclophosphamide pulse therapy, which led to beneficial effects. Given the rarity of multiple EGPA-associated cerebral artery stenoses and SAH, it is crucial to differentiate them from other diseases. The mortality rate of EGPA complicated by intracranial hemorrhagic lesions, including SAH, is high. When headache is present at the onset of EGPA, the possibility of SAH must be considered.

Indexed as

Remission InductionSubarachnoid HemorrhageChurg-Strauss SyndromeConstriction, PathologicCyclophosphamideFemaleGranulomatosis with PolyangiitisHumansMiddle AgedCyclophosphamideANCA-associated vasculitis (AAV)central nerve system involvementeosinophilic granulomatosis with polyangiitis (EGPA)multiple cerebral artery stenosesperipheral neuropathysubarachnoid hemorrhaging (SAH)

Identifiers

PMID38719596
PMCPMC11729179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.